Showing results (1171-1180 of 1,718) with videos related to
Sort By:
Pageof 172
The New England Journal of Medicine|September 28, 1989
Risk factors for human immunodeficiency virus infection in intravenous drug usersE E Schoenbaum, D Hartel, P A Selwyn, et al.AJNR. American Journal of Neuroradiology|June 5, 1998
Sex and electroencephalographic synchronization after photic stimulation predict signal changes in the visual cortex on functional MR imagesP Hedera, D Wu, S Collins, et al.The Journal of Infectious Diseases|June 22, 2013
Interleukin 1 enhances vaccine-induced antifungal T-helper 17 cells and resistance against Blastomyces dermatitidis infectionMarcel Wüthrich, Vanessa LeBert, Kevin Galles, et al.Proteomics|May 17, 2012
Early changes in the liver-soluble proteome from mice fed a nonalcoholic steatohepatitis inducing dietAnja Thomas, Axel P Stevens, Matthias S Klein, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 20, 2001
IL-9 and IL-13 production by activated mast cells is strongly enhanced in the presence of lipopolysaccharide: NF-kappa B is decisively involved in the expression of IL-9M Stassen, C Müller, M Arnold, et al.The Journal of Audiovisual Media in Medicine|March 31, 2001
Video-based computer-assisted learningN M Hamilton, G Fairhurst, S Pavett, et al.Obstetrics and Gynecology|March 15, 2003
Incident and persistent vulvovaginal candidiasis among human immunodeficiency virus-infected women: Risk factors and severityAnn Duerr, Charles M Heilig, Susan F Meikle, et al.American Journal of Public Health|January 1, 1995
Heroin use during methadone maintenance treatment: the importance of methadone dose and cocaine useD M Hartel, E E Schoenbaum, P A Selwyn, et al.AIDS Patient Care and Stds|October 14, 2008
Use of complementary and alternative medicine in inner-city persons with or at risk for HIV infectionFelise B Milan, Julia H Arnsten, Robert S Klein, et al.Proceedings of the National Academy of Sciences of the United States of America|April 18, 2009
Examination of the contributions of size and avidity to the neutralization mechanisms of the anti-HIV antibodies b12 and 4E10Joshua S Klein, Priyanthi N P Gnanapragasam, Rachel P Galimidi, et al.Pageof 172